SCHICKLER MICHAEL enters PURPLE BIOTECH LTD. with 9.25M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/30/2026ACC: 0001213900-26-036361
Officer· Head of Clinical & Reg Affairs
Since Mar 2026
9.25M
Baseline shares
100% direct
9.25M
Direct ownership
1 position
9.05M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned9.25M
Total
9.25M direct9.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 9.25M | Direct |
| Total | 9.25M | 9.25M direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
900K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
151K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
7.10M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
900K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
9.05M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 900K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 151K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 7.10M | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 900K | N/A | |
| Total | 9.05M | 0.00 | ||||